Kaushal Asrani

Dr. Kaushal Asrani

Johns Hopkins School of Medicine, Baltimore, MD, USA

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 November 2022 in Nature Communications
Verified
Journal Article
Open access
PDF file
KAKaushal Asrani
Kaushal Asrani
JWJuhyung Woo
Juhyung Woo
AMAdrianna A. Mendes
Adrianna A. Mendes
ESEthan Schaffer
Ethan Schaffer
TVThiago Vidotto
Thiago Vidotto
TLTamara L. Lotan
Tamara L. Lotan
The mechanistic target of rapamycin complex 1 (mTORC1) integrates inputs from growth factors and nutrients, but how mTORC1 autoregulates its activity remains unclear. The MiT/TFE transcription factors are phosphorylated and inactivated by mTORC1 following lysosomal recruitment by RagC/D GTPases in response to amino acid stimulation. We find that starvation-induced lysosomal localization of the RagC/D GAP complex, FLCN:FNIP2, is markedly impaired in a mTORC1-sensitive manner in renal cells with TSC2 loss, resulting in unexpected TFEB hypophosphorylation and activation upon feeding. TFEB phosphorylation in TSC2-null renal cells is partially restored by destabilization of the lysosomal folliculin complex (LFC) induced by FLCN mutants and is fully rescued by forced lysosomal localization of the FLCN:FNIP2 dimer. Our data indicate that a negative feedback loop constrains amino acid-induced, FLCN:FNIP2-mediated RagC activity in renal cells with constitutive mTORC1 signaling, and the resulting MiT/TFE hyperactivation may drive oncogenesis with loss of the TSC2 tumor suppressor.

19 November 2024 in Human Pathology
Verified
Journal Article
Closed access
AAAmir Akbari
Amir Akbari
CVClarence Rachel Villanueva
Clarence Rachel Villanueva
OHOndrej Hes
Ondrej Hes
SWSean R. Williamson
Sean R. Williamson
SKShivani Kandukuri
Shivani Kandukuri
TLTamara L. Lotan
Tamara L. Lotan

3 October 2025 in Nature Communications
Verified
Journal Article
Open access
PDF file
KAKaushal Asrani
Kaushal Asrani
AAAdrianna Amaral
Adrianna Amaral
JWJuhyung Woo
Juhyung Woo
SASanaz Nourmohammadi Abadchi
Sanaz Nourmohammadi Abadchi
TVThiago Vidotto
Thiago Vidotto
TLTamara L. Lotan
Tamara L. Lotan
MiT/TFE gene fusions like SFPQ-TFE3 drive both epithelial (translocation RCC) and mesenchymal (PEComas) neoplasms. However, no mouse models for SFPQ-TFE3-related tumors exist and the underlying mechanisms of lineage plasticity remain unclear. Here, we demonstrate that constitutive murine renal expression of SFPQ-TFE3 disrupts kidney development with early neonatal renal failure and death, while post-natal induction induces infiltrative epithelioid tumors, that morphologically and transcriptionally resemble human PEComas, with strong activation of mTORC1 signaling via increased V-ATPase expression. Remarkably, SFPQ-TFE3 expression is sufficient to induce lineage plasticity, with down-regulation of the PAX2/PAX8 nephric lineage factors and tubular epithelial markers, and up-regulation of PEComa differentiation markers in transgenic mice, cell lines and human tRCC. mTOR inhibition downregulates SFPQ-TFE3 expression and rescues PAX8 expression and transcriptional activity in vitro. These data provide evidence of an epithelial cell-of-origin for TFE3-driven PEComas, highlighting a reciprocal role for SFPQ-TFE3 and mTOR in driving lineage plasticity in the kidney.

2 November 2025 in The Journal of Pathology
Verified
Journal Article
Closed access
HLHuili Li
Huili Li
AAAdrianna Amaral
Adrianna Amaral
TVThiago Vidotto
Thiago Vidotto
JWJuhyung Woo
Juhyung Woo
HLHans B Liu
Hans B Liu
KAKaushal Asrani
Kaushal Asrani

22 November 2024 in bioRxiv
Verified
Preprint
Open access
PDF file
KAKaushal Asrani
Kaushal Asrani
AAAdrianna Amaral
Adrianna Amaral
JWJuhyung Woo
Juhyung Woo
SASanaz Nourmohammadi Abadchi
Sanaz Nourmohammadi Abadchi
TVThiago Vidotto
Thiago Vidotto
TLTamara L. Lotan
Tamara L. Lotan
Summary: The MiT/TFE family gene fusion proteins, such as SFPQ-TFE3 , drive both epithelial (eg, translocation renal cell carcinoma, tRCC) and mesenchymal (eg, perivascular epithelioid cell tumor, PEComa) neoplasms with aggressive behavior. However, no prior mouse models for SFPQ-TFE3 -related tumors exist and the mechanisms of lineage plasticity induced by this fusion remain unclear. Here, we demonstrate that constitutive murine renal expression of human SFPQ-TFE3 using Ksp Cadherin-Cre as a driver disrupts kidney development leading to early neonatal renal failure and death. In contrast, post-natal induction of SFPQ-TFE3 in renal tubular epithelial cells using Pax8 ERT-Cre induces infiltrative epithelioid tumors, which morphologically and transcriptionally resemble human PEComas. As seen in MiT/TFE fusion-driven human tumors, SFPQ-TFE3 expression is accompanied by the strong induction of mTORC1 signaling, which is partially amino acid-sensitive and dependent on increased SFPQ-TFE3 -mediated RRAGC/D transcription. Remarkably, SFPQ-TFE3 expression is sufficient to induce lineage plasticity in renal tubular epithelial cells, with rapid down-regulation of the critical PAX2/PAX8 nephric lineage factors and tubular epithelial markers, and concomitant up-regulation of PEComa differentiation markers in transgenic mice, human cell line models and human tRCC. Pharmacologic or genetic inhibition of mTOR signaling downregulates expression of the SFPQ-TFE3 fusion protein and rescues nephric lineage marker expression and transcriptional activity in vitro. These data provide evidence of a potential epithelial cell-of-origin for TFE3 -driven PEComas and highlight a reciprocal role for SFPQ-TFE3 and mTOR in driving lineage plasticity in the kidney, expanding our understanding of the pathogenesis of MiT/TFE-driven tumors.

4 August 2026
Verified
Other
Open access
PDF file
AAAdrianna Amaral
Adrianna Amaral
TVThiago Vidotto
Thiago Vidotto
JWJuhyung Woo
Juhyung Woo
MRMichael Rubenstein
Michael Rubenstein
JLJiayun Lu
Jiayun Lu
TLTamara L. Lotan
Tamara L. Lotan
Supplementary Table S8. Difference in Median HLA Average H-score in Combined Cohorts by Race.